Oncology Archives - Page 4 of 23

Leveraging social media data to study disease and treatment characteristics of Hodgkin’s lymphoma Using Natural Language Processing methods

Authors: Z A Siddiqui, M Pathan, S Nduaguba, T LeMasters, V G Scott 1, U Sambamoorthi, J S Patel Published: PLOS digital health, 2025 View publication Background The use of social media...

A US survey across seven early-stage cancers assessing the humanistic burden of recurrence on patients and caregivers

Authors: R Aguiar-Ibáñez, K McQuarrie, A Martinez, H Penton, L DiGiovanni, R Raina, M Heisen, S Jayade Published: Oncology and therapy, 2025 View publication Introduction Patients diagnosed with an early-stage cancer are...

ESMO2024 highlights: Combining scientific expertise and humanized-AI insights

The ESMO2024 conference, held in Barcelona last week, highlighted important and innovative advancements in oncology and showcased new developments that could significantly improve patient care across various tumor types. Blessed with sunny...

Real-world treatment patterns and clinical outcomes from a retrospective chart review study of patients with recurrent or advanced endometrial cancer who progressed following prior systemic therapy in Europe

Authors: J Zhang, S S Kelkar, V S Prabhu, Y Qiao, V Grall, N Miles, C Marth Published: BMJ Open, 2024 View publication Objective To evaluate real-world treatment patterns and clinical outcomes...

Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe

Authors: S S Kelkar, V S Prabhu, J Zhang, Y M Ogando, K Roney, R P Verma, N Miles, C Marth Published: Archives of Gynecology and Obstetrics, 2024 View publication Purpose To...

Innovation in Oncology Clinical Trials: Transforming Research With Cutting-Edge Clinical Trial Designs and Technologies

In recent years, there has been an increased focus on adopting innovative and often complex clinical trial designs in oncology to assess the value of newly identified molecularly targeted agents in specific...

Patients’ willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer

Authors: M Boeri, M K Skelsey, J A Schiro, S E Dozier, R Glinert, M M Okun Published: The Journal of Dermatological Treatment, 2023 View publication Background Non-immunosuppressed patients with a history...

Population health model predicting the long-term impact of sotatercept on morbidity and mortality in patients with Pulmonary Arterial Hypertension (PAH)

Authors: V McLaughlin, A Alsumali, R Liu, R Klok, E C Martinez, I Nourhussein, D Bernotas, J Chevure, C Pausch, J D O Pena, D Lautsch & M M Hoeper Published: Advances...

Perspectives of healthcare professionals on the management and treatment of advanced ovarian cancer in the UK: results from the KNOW-OC survey

Authors: C Fotopoulou, M Hall, R Lord, R Miller, S Sundar, N Roebuck, L Fildes, A Wesselbaum, S McCormack, J Hickey, J Ledermann Published: Clinical oncology (Royal College of Radiologists (Great Britain)),...

News